Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTasty Regulatory News (TAST)

  • There is currently no data for TAST

Placing and Director/PDMR Shareholdings

11 Oct 2013 08:46

RNS Number : 2953Q
Tasty PLC
11 October 2013
 



Tasty Plc ("Tasty" or the "Company")

Placing and Director/PDMR Shareholdings

The Company is pleased to announce a placing to raise £2.5million. Further the Company also today announces changes to certain Directors interests in the ordinary shares of 10 pence each ("Ordinary Shares") and incentive arrangements in the Ordinary Shares.

The Placing

The Company today announces that it has raised £2.5million, before expenses, through a placing of 2,500,000 new Ordinary Shares ("New Shares") at a price of 100 pence per share (the "Placing Price") (the "Placing"). The Placing Price represents a discount of 4 per cent. to the closing middle market price of the Company on 10 October 2013 (being the latest practicable date prior to this announcement). The New Shares represent approximately 5.22 per cent. of the current issued share capital of the Company. The Placing is conditional upon admission of the New Shares to trading on AIM and is not underwritten.

The net proceeds from the Placing will be used by the Company to fund the continued expansion of restaurants within the Company.

As part of the Placing certain Directors of the Company have subscribed for New Shares at the Placing Price as set out below:

Name

Title

No. of New Shares subscribed for under the Placing

Samuel Kaye

Joint Chief Executive

150,000

Adam Kaye

Non-Executive Director

150,000

Keith Lassman, Chairman of the Company, has also subscribed for 10,000 Ordinary Shares at the Placing Price.

 

The directors of the Company (excluding Samuel Kaye and Adam Kaye), having consulted the Company's nominated adviser, consider the subscription for New Shares by Samuel Kaye and Adam Kaye to be fair and reasonable insofar as the Company's shareholders are concerned.

 

Application will be made for 2,510,000 Ordinary Shares, being issued as part of the Placing and subscription, to be admitted to trading on AIM and dealings are expected to commence on 18 October 2013.

Director Exercise of Options

Each of the directors of the Company ("the "Directors") has informed the Company that they intend to shortly exercise options granted under the Company's share option plan for approved awards and also as unapproved options. The performance conditions attached to these options have been met in full.

In order to settle exercise costs and tax liabilities on exercise, the Directors will sell, in total, 1,463,672 Ordinary Shares at a price of 100 pence per shares ("Directors Sale"). Details of exercise and sales are set out below:

Name

Title

No. of options exercised

No. of Ordinary Shares sold following the exercise of options

No. of Ordinary Shares retained following the exercise of options

Jonny Plant

Joint Chief Executive

1,029,922

511,391

518,531

Samuel Kaye

Joint Chief Executive

500,000

332,230

167,770

Non-Executive Director

500,000

332,230

167,770

Keith Lassman

Chairman

219,230

163,910

55,320

In addition to the above, another option holder will exercise options over 240,000 Ordinary Share.

Application will be made for 2,489,152 new Ordinary Shares to be issued following the exercise of options to be admitted to trading on AIM and dealings are expected to commence on 17 October 2013.

New Options

The Remuneration Committee of the Company has committed to grant new options over Ordinary Shares to certain Directors related to new performance targets ("New Options"). The details of these grants are set out below:

Name

Title

No. of New Options Granted

Exercise price of the New Options

Jonny Plant

Joint Chief Executive

500,000

100 pence

Samuel Kaye

Joint Chief Executive

500,000

100 pence

Adam Kaye

Non-Executive Director

500,000

100 pence

The options will be exercisable subject to the share price of the Company having an average closing mid-market price of £1.50 for fifteen (15) consecutive trading days.

The board of the Company is exploring a number of option or option equivalent incentive schemes under which to grant the above New Options.

Director/PDMR Shareholdings

Following the Placing, the Directors Sale and the grant of New Options the Directors will be interested in the following number of Ordinary Shares in the Company:

Name

Title

No. Ordinary Shares

% of the issued share capital of the Company as enlarged by the Placing and the exercise of options

Total number of options over Ordinary Shares held following exercise and grant of New Options

Jonny Plant

Joint Chief Executive

4,194,877

7.93%

500,000

Samuel Kaye

Joint Chief Executive

9,690,240

18.31%

500,000

Adam Kaye

Non-Executive Director

7,940,238

15.00%

500,000

Keith Lassman

Chairman

134,640

0.25%

0

Total Voting Rights

In accordance with the FSA's Disclosure and Transparency Rules, the Company wishes to notify the market that following the Placing and the exercise of options the Company's issued share capital will consist of 52,927,101 ordinary shares of 10 pence each ("Ordinary Shares"), all with voting rights. No shares were held in treasury at the date of this announcement. The total number of current voting rights in the Company is therefore 52,927,101.

The above figure (52,927,101 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company.

11 October 2013

Enquiries

Tasty plc

Jonny Plant Tel: 020 7637 1166

Cenkos Securities plc

Bobbie Hilliam Tel: 020 7071 4300

NOMAD and Broker

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGGWCUUPWUMG
Date   Source Headline
9th Sep 20252:42 pmRNSChange of Name
4th Sep 20254:54 pmRNSHolding(s) in Company
4th Sep 20253:37 pmRNSHolding(s) in Company
4th Sep 202512:17 pmRNSHolding(s) in Company
3rd Sep 202512:00 pmRNSResult of General Meeting and Board Changes
6th Aug 20252:22 pmRNSResult of Retail Offer, Revised Timetable & TVR
4th Aug 20257:00 amRNSResult of Placing and Subscription
1st Aug 20254:35 pmRNSRetail Offer
1st Aug 20254:30 pmRNSProposed Fundraising
28th Jul 202511:27 amRNSResponse to Press Speculation
25th Jun 20256:17 pmRNSHolding(s) in Company
19th Jun 20252:04 pmRNSResult of AGM
7th May 20257:00 amRNSFinal Results
13th Feb 20259:30 amRNSHolding(s) in Company
24th Jan 20257:00 amRNSTrading Update
2nd Jan 20257:00 amRNSInsurance Settlement and Trading Update
30th Sep 20247:00 amRNSHalf-year Report
29th Jul 20244:44 pmRNSHolding(s) in Company
22nd Jul 20242:54 pmRNSResult of AGM & GM
5th Jul 20245:49 pmRNSHolding(s) in Company
3rd Jul 202412:07 pmRNSDirector/PDMR Shareholding
1st Jul 20244:30 pmRNSShare Authorities, Circular & Notice of GM
28th Jun 20245:30 pmRNSPublication of Annual Report and Notice of AGM
28th Jun 20247:00 amRNSFinal Results
4th Jun 20243:50 pmRNSResult of Sanction Hearing and Restructuring Plan
13th May 202412:30 pmRNSRestructuring Plan - Update
3rd May 20244:00 pmRNSRestructuring Plan - Update
9th Apr 202410:47 amRNSTrading Update, Restructuring Plan and Loan
7th Nov 20239:20 amRNSChange of Nominated Adviser and Broker
27th Sep 20237:00 amRNSHalf-year Report
6th Jun 202312:23 pmRNSResult of AGM
15th May 20233:34 pmRNSPosting of Report & Accounts and Notice of AGM
30th Mar 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
19th Sep 20227:00 amRNSHalf-year Report
1st Jul 20227:00 amRNSTotal Voting Rights
30th Jun 20226:10 pmRNSHolding(s) in Company
28th Jun 20224:30 pmRNSHolding(s) in Company
23rd Jun 20224:10 pmRNSRepayment of Bank Facility
22nd Jun 20227:00 amRNSDirectorate Changes and Conversion of B Shares
11th May 20223:25 pmRNSResult of AGM
14th Apr 20224:30 pmRNSPosting of Report & Accounts and Notice of AGM
23rd Mar 20227:00 amRNSFinal Results
8th Mar 20227:00 amRNSTrading Update
4th Jan 20227:00 amRNSTrading Update
27th Sep 20217:00 amRNSHalf-year Report
29th Jun 20217:00 amRNSTrading Update
2nd Jun 202111:33 amRNSHolding(s) in Company
21st May 20211:01 pmRNSOperational Update
19th May 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.